Indaptus Therapeutics (INDP) Current Leases (2021 - 2025)
Indaptus Therapeutics (INDP) posted quarterly Current Leases of $8686.0 for Q3 2025, down 91.65% year-over-year from $103982.0 in Q3 2024, and down 74.73% quarter-over-quarter from $34373.0 in Q2 2025.
Indaptus Therapeutics (INDP) Current Leases (2021 - 2025) Analysis & Trends
Indaptus Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $8686.0 for Q3 2025.
- In Q3 2025, Current Leases fell 91.65% year-over-year to $8686.0; the TTM figure through Sep 2025 stood at $8686.0 (down 91.65% YoY), while the FY2024 annual figure was $84164.0, down 17.25% from the prior year.
- Current Leases for Q3 2025 stood at $8686.0, down from $34373.0 in the prior quarter.
- The five-year high for Current Leases was $103982.0 in Q3 2024, with the low at $8686.0 in Q3 2025.
- The 5-year median for Current Leases is $98265.0 (2022), against an average of $85627.8.
- The sharpest annual moves came in 2023 and 2025: Current Leases rose 26.35% in 2023, then sank 91.65% in 2025.
- Indaptus Therapeutics' Current Leases stood at $96465.0 in 2021, then decreased by 16.56% to $80494.0 in 2022, then increased by 26.35% to $101705.0 in 2023, then retreated by 17.25% to $84164.0 in 2024, then sank by 89.68% to $8686.0 in 2025.
- Business Quant data shows INDP's Current Leases at $8686.0 in Q3 2025, $34373.0 in Q2 2025, and $59512.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Indaptus Therapeutics | 146.91 Mn | 135.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8,686.00 |
| Jun 30, 2025 | 34,373.00 |
| Mar 31, 2025 | 59,512.00 |
| Dec 31, 2024 | 84,164.00 |
| Sep 30, 2024 | 103,982.00 |
| Jun 30, 2024 | 103,223.00 |
| Mar 31, 2024 | 102,464.00 |
| Dec 31, 2023 | 101,705.00 |
| Sep 30, 2023 | 101,004.00 |
| Jun 30, 2023 | 100,421.00 |
| Mar 31, 2023 | 99,837.00 |
| Dec 31, 2022 | 80,494.00 |
| Sep 30, 2022 | 98,625.00 |
| Jun 30, 2022 | 97,905.00 |
| Mar 31, 2022 | 97,185.00 |
| Dec 31, 2021 | 96,465.00 |